AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10726794 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost (after switching from Timolol)
Number of subjects: 255
Study 8817300 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 1356175 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly pulse methylprednisolone for 6 months
Number of subjects: 65
Study 1356175 — intervention group
Group type: COMPARATOR
Intervention: Monthly pulse cyclophosphamide for 6 months
Number of subjects: 65
Study 1356175 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly cyclophosphamide for 6 months followed by quarterly pulse cyclophosphamide for 2 additional years
Number of subjects: 65
Study 3893195 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (3‐600 micrograms, six hourly)
Number of subjects: 20
Study 3893195 — intervention group
Group type: COMPARATOR
Intervention: Chlormethiazole (500‐1000 mg, six hourly)
Number of subjects: 20
Study 30037309 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat graft enriched with platelet-rich plasma (group 1)
Number of subjects: 50
Study 30037309 — intervention group
Group type: COMPARATOR
Intervention: Cartilage perichondrium graft (group 2)
Number of subjects: 50
Study 29341834 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib, Lenalidomide, and Dexamethasone (KRd)
Number of subjects: 0
Study 29341834 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide and Dexamethasone (Rd)
Number of subjects: 0
Study 26771294 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (3 g/day)
Number of subjects: 40
Study 26771294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 23460415 — intervention group
Group type: EXPERIMENTAL
Intervention: VESTAsync™ Eluting Stent (VES)
Number of subjects: 75
Study 23460415 — intervention group
Group type: COMPARATOR
Intervention: Control (Gen X stent)
Number of subjects: 75
Study 22313079 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g intravenous paracetamol intraoperatively
Number of subjects: 30
Study 22313079 — intervention group
Group type: COMPARATOR
Intervention: 1.0 g oral paracetamol 30 to 60 minutes preoperatively
Number of subjects: 30
Study 20816966 — intervention group
Group type: EXPERIMENTAL
Intervention: Social exclusion (SE)
Number of subjects: 67
Study 20816966 — intervention group
Group type: COMPARATOR
Intervention: Technical default (TD)
Number of subjects: 67
Study 20816966 — intervention group
Group type: COMPARATOR
Intervention: Social inclusion (SI)
Number of subjects: 67
Study 17394063 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrument developed for sedation choice
Number of subjects: 194
Study 17394063 — intervention group
Group type: COMPARATOR
Intervention: Standard sedation practice (Control)
Number of subjects: 194
Study 15382064 — intervention group
Group type: EXPERIMENTAL
Intervention: DRB1*04 tumors
Number of subjects: 52
Study 15382064 — intervention group
Group type: COMPARATOR
Intervention: non-DRB1*04 tumors
Number of subjects: 52
Study 15382064 — intervention group
Group type: EXPERIMENTAL
Intervention: DRB1*07 tumors
Number of subjects: 52
Study 15382064 — intervention group
Group type: EXPERIMENTAL
Intervention: DR+ tumors
Number of subjects: 52
Study 11438134 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-band UVB
Number of subjects: 73
Study 11438134 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA
Number of subjects: 73
Study 11438134 — intervention group
Group type: COMPARATOR
Intervention: Visible fluorescent light
Number of subjects: 73
Study 9685104 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (group A, n=60 patients)
Number of subjects: 80
Study 9685104 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (group B, n=20 patients)
Number of subjects: 80
Study 7924632 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin and cortisol circadian rhythms in elderly subjects with dementia
Number of subjects: 56
Study 7924632 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) suppression test (1 mg orally at 2300)
Number of subjects: 56
Study 7924632 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic corticotropin (Synacthen 2,500 ng) pulse i.v. injection
Number of subjects: 56
Study 2625543 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance tasks at contraction levels of 5, 10, 15, 20, 30, 40, and 50% MVC
Number of subjects: 12
Study 2625543 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance tasks at contraction levels less than 70 N
Number of subjects: 12
Study 2625543 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary contraction (MVC) measured at the wrist with elbow at right angle
Number of subjects: 12
Study 799560 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 20
Study 799560 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 20
Study 799560 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol plus Hydrochlorothiazide
Number of subjects: 20
Study 799560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 799560 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic (Hydrochlorothiazide)
Number of subjects: 20
Study 799560 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-receptor blockade (Timolol)
Number of subjects: 20
Study 799560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (Timolol plus Hydrochlorothiazide)
Number of subjects: 20
Study 30644983 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT) with cyclophosphamide (200 mg/kg) and antithymocyte globulin (6 mg/kg)
Number of subjects: 110
Study 30644983 — intervention group
Group type: COMPARATOR
Intervention: Disease-modifying therapy (DMT) of higher efficacy or a different class than DMT taken during the previous year
Number of subjects: 110
Study 30644983 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT)
Number of subjects: 110
Study 30644983 — intervention group
Group type: COMPARATOR
Intervention: Disease-modifying therapy (DMT)
Number of subjects: 110
Study 28901892 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanin (ACN) supplementation (320 mg/d)
Number of subjects: 16
Study 28901892 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO) treatment
Number of subjects: 16
Study 25567475 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated sugar-sweetened beverage (C-SSB)
Number of subjects: 99
Study 25567475 — intervention group
Group type: COMPARATOR
Intervention: Non-caffeinated sugar-sweetened beverage (NC-SSB)
Number of subjects: 99
Study 23885658 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% CS
Number of subjects: 60
Study 23885658 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% N-9
Number of subjects: 60
Study 23885658 — intervention group
Group type: COMPARATOR
Intervention: Universal HEC placebo
Number of subjects: 60
Study 21310372 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary adenosine (1 to 2 mg) administered 2 times during PCI
Number of subjects: 70
Study 21310372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 19282342 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance time (ET) during exercise
Number of subjects: 463
Study 19282342 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory capacity (IC) at rest, isotime, and peak exercise
Number of subjects: 463
Study 19282342 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation during exercise
Number of subjects: 463
Study 19282342 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnoea intensity at isotime and peak exercise
Number of subjects: 463
Study 16753388 — intervention group
Group type: EXPERIMENTAL
Intervention: DUR‐8 Elite
Number of subjects: 192
Study 16753388 — intervention group
Group type: EXPERIMENTAL
Intervention: URF‐P3
Number of subjects: 192
Study 16392437 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study 16392437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12351451 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50
Study 12351451 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 50
Study 10579068 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 0
Study 10579068 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive nuclear imaging (SPECT and PET) and stress echocardiography
Number of subjects: 0
Study 8775856 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 25
Study 8775856 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 25
Study 8775856 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study 2148223 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine SRO (5 mg) given at either 9 am or 9 pm
Number of subjects: 22
Study 383311 — intervention group
Group type: EXPERIMENTAL
Intervention: BRL‐10833 (mast cell stabiliser)
Number of subjects: 25
Study 383311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 31303025 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid Intima-Media Thickness (IMT)
Number of subjects: 952
Study 31303025 — intervention group
Group type: EXPERIMENTAL
Intervention: Plaque
Number of subjects: 952
Study 31303025 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombotic occlusion in CLI
Number of subjects: 952
Study 31303025 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT
Number of subjects: 952
Study 31303025 — intervention group
Group type: COMPARATOR
Intervention: IMT thresholds
Number of subjects: 952
Study 30771329 — intervention group
Group type: EXPERIMENTAL
Intervention: MiECC (Miniaturized Extracorporeal Circulation)
Number of subjects: 128
Study 30771329 — intervention group
Group type: COMPARATOR
Intervention: Standard Extracorporeal Circulation
Number of subjects: 128
Study 30771329 — intervention group
Group type: EXPERIMENTAL
Intervention: MiECC
Number of subjects: 128
Study 28129989 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored risk letter and invitation to attend a no-commitment introductory session run by the local SSS
Number of subjects: 4384
Study 28129989 — intervention group
Group type: COMPARATOR
Intervention: Standard generic letter advertising the local SSS
Number of subjects: 4384
Study 26201254 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan (angiotensin II receptor blocker)
Number of subjects: 293
Study 26201254 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 293
Study 23448396 — intervention group
Group type: COMPARATOR
Intervention: hCG 0 IU/day (Control)
Number of subjects: 62
Study 23448396 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 50 IU/day
Number of subjects: 62
Study 23448396 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 100 IU/day
Number of subjects: 62
Study 23448396 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG 150 IU/day
Number of subjects: 62
Study 23448396 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (all doses)
Number of subjects: 62
Study 23448396 — intervention group
Group type: EXPERIMENTAL
Intervention: SHBG (all doses)
Number of subjects: 62
Study 23448396 — intervention group
Group type: EXPERIMENTAL
Intervention: AMH (all doses)
Number of subjects: 62
Study 20965292 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg
Number of subjects: 10
Study 20965292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 19298950 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep lamellar endothelial keratoplasty (DLEK)
Number of subjects: 25
Study 19298950 — intervention group
Group type: COMPARATOR
Intervention: Penetrating keratoplasty (PK)
Number of subjects: 25
Study 18008201 — intervention group
Group type: EXPERIMENTAL
Intervention: White Light Endoscopy (WLE)
Number of subjects: 51
Study 18008201 — intervention group
Group type: EXPERIMENTAL
Intervention: Autofluorescence Endoscopy (AFE)
Number of subjects: 51
Study 18008201 — intervention group
Group type: EXPERIMENTAL
Intervention: WLE followed by AFE
Number of subjects: 51
Study 15588275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol levels in patients with CFS
Number of subjects: 43
Study 15588275 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone levels (FSH, LH, estradiol, progesterone) in patients with CFS
Number of subjects: 43
Study 15588275 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone levels in patients with high depression scores
Number of subjects: 43
Study 11487293 — intervention group
Group type: EXPERIMENTAL
Intervention: Redundant target visual search
Number of subjects: 0
Study 11487293 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of fluctuations in discrimination accuracy at threshold
Number of subjects: 0
Study 9580774 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 15
Study 9580774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8306829 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal occult blood testing (six tests offered)
Number of subjects: 27700
Study 8306829 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fecal occult blood testing)
Number of subjects: 27700
Study 2728826 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE) cannulae (n = 11)
Number of subjects: 32
Study 2728826 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermoplastic polyether‐urethane (TPEU) cannulae (n = 11)
Number of subjects: 32
Study 2728826 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyamide‐ether-elastomer (XLON) cannulae (n = 10)
Number of subjects: 32
Study 811076 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam (Rivotril(R)) combined with previous anti-epileptic drugs
Number of subjects: 17
Study 811076 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with previous anti-epileptic drugs
Number of subjects: 17
Study 31440031 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal Yimaxin
Number of subjects: 16
Study 31440031 — intervention group
Group type: COMPARATOR
Intervention: Vaginal Utrogestan
Number of subjects: 16
Study 31440031 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Yimaxin
Number of subjects: 16
Study 31440031 — intervention group
Group type: COMPARATOR
Intervention: Oral Utrogestan
Number of subjects: 16
Study 28534417 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based training with telemonitoring guidance
Number of subjects: 90
Study 28534417 — intervention group
Group type: COMPARATOR
Intervention: Centre-based training
Number of subjects: 90
Study 26044602 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1 mg/kg
Number of subjects: 90
Study 26044602 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 90
Study 26044602 — intervention group
Group type: COMPARATOR
Intervention: Saline 2 mL (Control)
Number of subjects: 90
Study 24112401 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase clostridium histolyticum (CCH) - investigational intralesional injection
Number of subjects: 832
Study 21577028 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib and Capecitabine
Number of subjects: 293
Study 18979269 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/0.5 kHz FPA
Number of subjects: 70
Study 18979269 — intervention group
Group type: EXPERIMENTAL
Intervention: IAD ratio
Number of subjects: 70
Study 16821181 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Hip Replacement (THR)
Number of subjects: 73
Study 16821181 — intervention group
Group type: COMPARATOR
Intervention: Control group (age matched population)
Number of subjects: 73
Study 15361775 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendrofluazide 2.5 mg daily
Number of subjects: 36
Study 15361775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 15361775 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 11517200 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous pumping with no massage
Number of subjects: 36
Study 11517200 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous pumping with massage
Number of subjects: 36
Study 11517200 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential pumping with no massage
Number of subjects: 36
Study 11517200 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential pumping with massage
Number of subjects: 36
Study 9313673 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (20 micrograms)
Number of subjects: 37
Study 9313673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 8452323 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide plus ciprofloxacin
Number of subjects: 88
Study 8452323 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin alone
Number of subjects: 88
Study 3614616 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1 mg orally prior to sleep)
Number of subjects: 0
Study 3614616 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (100 mg infusion throughout the night)
Number of subjects: 0
Study 3614616 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both steroids
Number of subjects: 0
Study 30446325 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional double puncture arthrocentesis
Number of subjects: 26
Study 30446325 — intervention group
Group type: EXPERIMENTAL
Intervention: Single puncture type 2 arthrocentesis
Number of subjects: 26
Study 30446325 — intervention group
Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 26
Study 27046309 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 2-4.5 mg/d
Number of subjects: 819
Study 27046309 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariprazine 1-2 mg/d
Number of subjects: 819
Study 27046309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 819
Study 24178787 — intervention group
Group type: EXPERIMENTAL
Intervention: tesamorelin
Number of subjects: 39
Study 24178787 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 39
Study 22168256 — intervention group
Group type: COMPARATOR
Intervention: Wearing one of seven respirators or a medical mask for 8 hr (or as long as tolerable) with interposed doffing periods every 2 hr
Number of subjects: 27
Study 21084615 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary punishment for recall performance
Number of subjects: 0
Study 21084615 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary reward for recall performance
Number of subjects: 0
Study 18480687 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR 150 mg/d
Number of subjects: 300
Study 18480687 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR 300 mg/d
Number of subjects: 300
Study 18480687 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion SR 400 mg/d
Number of subjects: 300
Study 18480687 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 16317652 — intervention group
Group type: EXPERIMENTAL
Intervention: Test rinse (IND 61,164)
Number of subjects: 32
Study 16317652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 12583945 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission cardiotocography (20 min)
Number of subjects: 8580
Study 12583945 — intervention group
Group type: COMPARATOR
Intervention: Usual care (intermittent auscultation only)
Number of subjects: 8580
Study 12583945 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission cardiotocography
Number of subjects: 8580
Study 11395344 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour management training programme
Number of subjects: 62
Study 11395344 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 9918643 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Fuji Ortho glass ionomer cement (GC Industrial, Tokyo, Japan)
Number of subjects: 48
Study 9918643 — intervention group
Group type: COMPARATOR
Intervention: System 1+ composite resin (Ormco, Glendora, CA)
Number of subjects: 48
Study 7941663 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol 0.1%
Number of subjects: 14
Study 7941663 — intervention group
Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 14
Study 3793916 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral morphine, every 4 h
Number of subjects: 25
Study 3793916 — intervention group
Group type: COMPARATOR
Intervention: Injected meperidine (Demerol), every 3-4 h pro re nata
Number of subjects: 25
Study 31232139 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin (40 mg/d) combined with aspirin (100 mg/d)
Number of subjects: 120
Study 31232139 — intervention group
Group type: COMPARATOR
Intervention: Standard dose atorvastatin (20 mg/d) combined with aspirin (100 mg/d)
Number of subjects: 120
Study 26929396 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 32
Study 26929396 — intervention group
Group type: COMPARATOR
Intervention: Positive expiratory pressure (PEP)
Number of subjects: 32
Study 25270609 — intervention group
Group type: EXPERIMENTAL
Intervention: Single port/incision laparoscopic surgery (SPILS)
Number of subjects: 79
Study 25270609 — intervention group
Group type: COMPARATOR
Intervention: Standard three-port laparoscopic surgery
Number of subjects: 79
Study 22952201 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully supervised center‐based exercise (FS)
Number of subjects: 119
Study 22952201 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally supervised home‐based exercise (MS)
Number of subjects: 119
Study 22952201 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise controls (C)
Number of subjects: 119
Study 22046814 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg glimepiride
Number of subjects: 24
Study 18981033 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided treatment (measured BNP concentrations at 12 and 24 hours after the first dose of indomethacin, withholding doses if BNP <100 pg/ml)
Number of subjects: 60
Study 18981033 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard indomethacin treatment without BNP guidance)
Number of subjects: 60
Study 18981033 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-guided treatment
Number of subjects: 60